Fardin Hashemi

732 total citations
9 papers, 601 citations indexed

About

Fardin Hashemi is a scholar working on Molecular Biology, Molecular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Fardin Hashemi has authored 9 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Molecular Medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Fardin Hashemi's work include Curcumin's Biomedical Applications (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related molecular mechanisms research (2 papers). Fardin Hashemi is often cited by papers focused on Curcumin's Biomedical Applications (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related molecular mechanisms research (2 papers). Fardin Hashemi collaborates with scholars based in Iran, Türkiye and Pakistan. Fardin Hashemi's co-authors include Farid Hashemi, Milad Ashrafizadeh, Kiavash Hushmandi, Ali Zarrabi, Masoud Najafi, Ebrahim Rahmani Moghadam, Reza Mohammadinejad, Haroon Khan, Pooyan Makvandi and Maliheh Entezari and has published in prestigious journals such as Life Sciences, Frontiers in Pharmacology and Cellular Signalling.

In The Last Decade

Fardin Hashemi

9 papers receiving 595 citations

Peers

Fardin Hashemi

MB

CR

MM

ONCOL

BIOMA

Mahmood Khaksary Mahabady Iran

Rishi K. Gara India

Mehdi Sabzichi Iran

Fatemeh Ramezani Iran

Hassan Dariushnejad Iran

Ebrahim Rahmani Moghadam Iran

Jia‐Sin Yang Taiwan

Vinod Balachandran India

Nehal Gupta United States

Shravanti Mukherjee India

Mahmood Khaksary Mahabady Iran

Fardin Hashemi

335 ×1.0

MB

168 ×1.0

CR

92 ×0.8

MM

87 ×0.9

ONCOL

86 ×1.0

BIOMA

Citations per year, relative to Fardin Hashemi Fardin Hashemi (= 1×) peers Mahmood Khaksary Mahabady

Countries citing papers authored by Fardin Hashemi

Since Specialization

Citations

This map shows the geographic impact of Fardin Hashemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fardin Hashemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fardin Hashemi more than expected).

Fields of papers citing papers by Fardin Hashemi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fardin Hashemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fardin Hashemi. The network helps show where Fardin Hashemi may publish in the future.

Co-authorship network of co-authors of Fardin Hashemi

This figure shows the co-authorship network connecting the top 25 collaborators of Fardin Hashemi. A scholar is included among the top collaborators of Fardin Hashemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fardin Hashemi. Fardin Hashemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Mirzaei, Sepideh, Mahmood Khaksary Mahabady, Farid Hashemi, et al.. (2021). Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytotherapy Research. 36(1). 189–213. 155 indexed citations

2.

Soleymani, Leyla, Ali Zarrabi, Farid Hashemi, et al.. (2021). Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks. Current Cancer Drug Targets. 21(9). 749–767. 28 indexed citations

3.

Ashrafizadeh, Milad, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.. (2020). C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors. Current Cancer Drug Targets. 21(1). 2–20. 23 indexed citations

4.

Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines. 8(5). 110–110. 69 indexed citations

5.

Ashrafizadeh, Milad, Ali Zarrabi, Kiavash Hushmandi, et al.. (2020). Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators. Cellular Signalling. 78. 109871–109871. 115 indexed citations

6.

Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sciences. 256. 117984–117984. 122 indexed citations

7.

Ashrafizadeh, Milad, Ali Zarrabi, Kiavash Hushmandi, et al.. (2020). Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review. Frontiers in Pharmacology. 11. 585413–585413. 59 indexed citations

8.

Ashrafizadeh, Milad, Ali Zarrabi, Kiavash Hushmandi, et al.. (2020). MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life Sciences. 256. 117973–117973. 29 indexed citations

9.

Hashemi, Fardin, et al.. (2018). Clinical efficacy analysis of preoperative neoadjuvant chemotherapy with high-dose dense paclitaxel plus cisplatin in Stages IB2, IIA2, IIB cervical cancer in Iran.. PubMed. 37(5). 703–709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact